ConductScience.org, home

Paper41864909

A degradable multi-metal-chelating stealth nanoplatform for dual ferroptosis/cuproptosis-enhanced metalloimmunotherapy in leukemia.

Wang Y and 18 others. J Nanobiotechnology, 2026. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A degradable multi-metal-chelating stealth nanoplatform for dual ferroptosis/cuproptosis-enhanced metalloimmunotherapy in leukemia. Papers, record 41864909. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41864909

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A degradable multi-metal-chelating stealth nanoplatform for dual ferroptosis/cuproptosis-enhanced metalloimmunotherapy in leukemia.
PubMed
Journal
J Nanobiotechnology
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang YYingying
2Xu JJianxiang
3Bai WWenhui
4Zhang ZZiwei
5Ma CChunmin
6Tan YYayue
7Zhang ZZhenge
8Liu WWanting
9Wu YYunzhao
10Liu JJunchao
11Lei HHu
12Xu HHanzhang
13Weng WWei
14Huang MMei
15Feng XXiaoyang
16Zhu LLimin
17Yang LLi
18Zhu QQi
19Wu YLYing-Li

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FerroptosisMajor topic
Leukemia, Myeloid, AcuteMajor topic
NanoparticlesMajor topic
ImmunotherapyMajor topic
Chelating AgentsMajor topic
Antineoplastic AgentsMajor topic
Animals
Humans
Cuproptosis
Mice
Cell Line, Tumor
Copper
Iron
Manganese
Glutathione
Disulfiram
cGAS-STING Signaling Pathway

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2024M762019China Postdoctoral Science Foundation funded projectPubMed
82500203National Natural Science Foundation of ChinaPubMed
32300653National Natural Science Foundation of ChinaPubMed
(82170145,82100422,82322067,82470152,82400092National Natural Science Foundation of ChinaPubMed
21YF1423100Shanghai sailing programPubMed

Source PubMed

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136307534Targeting drugs to tumours using cell membrane-coated nanoparticles.Nat Rev Clin Oncol2023https://conductscience.org/library/papers/36307534PubMed
238594732Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology.Eur J Med Res2024https://conductscience.org/library/papers/38594732PubMed
325701030Mechanism of pH-switchable peroxidase and catalase-like activities of gold, silver, platinum and palladium.Biomaterials2015https://conductscience.org/library/papers/25701030PubMed
425769405Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer.Mol Oncol2015https://conductscience.org/library/papers/25769405PubMed
536572384An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.Transplant Cell Ther2023https://conductscience.org/library/papers/36572384PubMed
628518151Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2.Cell Death Dis2017https://conductscience.org/library/papers/28518151PubMed
732575749Ferroptosis and Cancer: Mitochondria Meet the "Iron Maiden" Cell Death.Cells2020https://conductscience.org/library/papers/32575749PubMed
839316723How I treat patients with AML using azacitidine and venetoclax.Blood2025https://conductscience.org/library/papers/39316723PubMed
930651634Targeting FLT3 mutations in AML: review of current knowledge and evidence.Leukemia2019https://conductscience.org/library/papers/30651634PubMed
1032601974Treatment of Relapsed Acute Myeloid Leukemia.Curr Treat Options Oncol2020https://conductscience.org/library/papers/32601974PubMed
1132839553Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.Cell Res2020https://conductscience.org/library/papers/32839553PubMed
1234045454FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm.Blood Cancer J2021https://conductscience.org/library/papers/34045454PubMed
1338148395Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia.Leukemia2024https://conductscience.org/library/papers/38148395PubMed
1439270538The novel prognostic analysis of AML based on ferroptosis and cuproptosis related genes.J Trace Elem Med Biol2024https://conductscience.org/library/papers/39270538PubMed
1531519186Iron and leukemia: new insights for future treatments.J Exp Clin Cancer Res2019https://conductscience.org/library/papers/31519186PubMed
1636510011The cGAS-STING pathway and cancer.Nat Cancer2022https://conductscience.org/library/papers/36510011PubMed
1736594187Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.Am J Hematol2023https://conductscience.org/library/papers/36594187PubMed
1836914548Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy.Sci Bull (Beijing)2023https://conductscience.org/library/papers/36914548PubMed
1924018392
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation.
Biol Blood Marrow Transplant2014https://conductscience.org/library/papers/24018392PubMed
2037974196Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death.Cell Commun Signal2023https://conductscience.org/library/papers/37974196PubMed

See all 38 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42459301The role and therapeutic potential of nanotechnology-mediated ferroptosis regulation in myelodysplastic syndromes.Front Oncol2026https://conductscience.org/library/papers/42459301

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CGAS115004PubTator's text mininghttps://conductscience.org/library/genes/115004NCBI Gene
STING1340061PubTator's text mininghttps://conductscience.org/library/genes/340061NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41864909

GET https://conductscience.org/api/papers/v1/41864909/references?page=2